[{"NetIncomeLoss_1_Q2_USD":-335202000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q2_USD":4602000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-9299000.0,"InventoryFinishedGoods_0_Q2_USD":29354000.0,"InterestPaidNet_2_Q2_USD":3354000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":207921000.0,"LiabilitiesNoncurrent_0_Q2_USD":805603000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q2_USD":-1103000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_2_Q2_USD":-2411000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q2_USD":750000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":1010230470.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":1007967904.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q2_USD":-1116000.0,"NetIncomeLossAttributableToNoncontrollingInterest_2_Q2_USD":-2320000.0,"ProvisionForDoubtfulAccounts_2_Q2_USD":121000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-1544864000.0,"Depreciation_2_Q2_USD":15146000.0,"Depreciation_1_Q2_USD":7679000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":0.0,"Assets_0_Q2_USD":3903290000.0,"UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount_0_Q2_USD":126864000.0,"CommonStockSharesIssued_0_Q2_shares":1014976692.0,"UnrecognizedTaxBenefits_0_Q2_USD":5783000.0,"IncomeTaxesPaidNet_2_Q2_USD":9250000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":45468000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":16569000.0,"EquityMethodInvestments_0_Q2_USD":26241000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":14307000.0,"DueToRelatedPartiesNoncurrent_0_Q2_USD":160164000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":124049000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":231130000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":2442943000.0,"LongTermDebtCurrent_0_Q2_USD":26061000.0,"AssetsCurrent_0_Q2_USD":3392404000.0,"ProceedsFromMinorityShareholders_2_Q2_USD":0.0,"CostOfGoodsAndServicesSold_2_Q2_USD":28456000.0,"PrepaidTaxes_0_Q2_USD":18792000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-4470000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":1228000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":15617000.0,"CommonStockValue_0_Q2_USD":102000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":-1475000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":79000.0,"AccountsReceivableNetCurrent_0_Q2_USD":61663000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":19976000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":23657000.0,"NoncontrollingInterestDecreaseFromDeconsolidation_1_Q2_USD":3545000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":-4287000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q2_USD":750000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":2941000.0,"InventoryRawMaterials_0_Q2_USD":3762000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":285968000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":590270000.0,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":-2628000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":0.0,"MinorityInterest_0_Q2_USD":10194000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":-2738000.0,"OtherSundryLiabilitiesNoncurrent_0_Q2_USD":174000.0,"CostsAndExpenses_2_Q2_USD":850327000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_2_Q2_USD":7406000.0,"Liabilities_0_Q2_USD":1356798000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":31165000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":1345014000.0,"ProceedsFromLongTermLinesOfCredit_2_Q2_USD":49525000.0,"OtherAssetsNoncurrent_0_Q2_USD":112382000.0,"AllowanceForDoubtfulAccountsReceivableRecoveries_2_Q2_USD":0.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":2883161000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":471000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":34851000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-337953000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-700235000.0,"IncreaseDecreaseInInventories_2_Q2_USD":4681000.0,"OtherPrepaidExpenseCurrent_0_Q2_USD":8933000.0,"RestrictedCash_0_Q2_USD":4885000.0,"CostsAndExpenses_1_Q2_USD":424512000.0,"AmortizationOfIntangibleAssets_1_Q2_USD":188000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q2_USD":-339056000.0,"UnrealizedGainLossOnInvestments_2_Q2_USD":11264000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":90620000.0,"ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_2_Q2_USD":997242000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-604886000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":1732000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":-2617000.0,"ProceedsFromShortTermDebt_2_Q2_USD":26197000.0,"InterestIncomeExpenseNet_1_Q2_USD":1108000.0,"InterestIncomeExpenseNet_2_Q2_USD":7798000.0,"Goodwill_0_Q2_USD":109000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":2470000.0,"OtherOperatingActivitiesCashFlowStatement_2_Q2_USD":-863000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":51157000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q2_USD":750000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q2_USD":750000.0,"CommonStockSharesOutstanding_0_Q2_shares":1014976692.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-9094000.0,"InventoryWorkInProcess_0_Q2_USD":118000.0,"DeconsolidationGainOrLossAmount_2_Q2_USD":11307000.0,"LiabilitiesCurrent_0_Q2_USD":551195000.0,"ValueAddedTaxReceivableNoncurrent_0_Q2_USD":25705000.0,"NetIncomeLoss_2_Q2_USD":-698937000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":258106000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":28962000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":11379000.0,"PrepaidInsurance_0_Q2_USD":6231000.0,"NumberOfOperatingSegments_2_Q2_segment":1.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":5375000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":729124000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":2546492000.0,"AccruedIncomeTaxesCurrent_0_Q2_USD":22564000.0,"LongTermDebtNoncurrent_0_Q2_USD":131491000.0,"DeferredIncomeTaxesAndTaxCredits_2_Q2_USD":-1060000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":28198000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":144466000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":1349899000.0,"AccountsPayableCurrent_0_Q2_USD":157173000.0,"AdditionalPaidInCapital_0_Q2_USD":5200275000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-2654780000.0,"TaxesPayableCurrent_0_Q2_USD":10448000.0,"CashDivestedFromDeconsolidation_2_Q2_USD":2025000.0,"InventoryNet_0_Q2_USD":33234000.0,"IncreaseDecreaseInAccruedIncomeTaxesPayable_2_Q2_USD":-3006000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":1807744000.0,"IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_2_Q2_USD":44471000.0,"AllowanceForDoubtfulAccountsReceivable_0_Q2_USD":121000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q2_USD":-337793000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2_Q2_USD":-701178000.0,"IncomeTaxReceivable_0_Q2_USD":5586000.0,"OperatingIncomeLoss_1_Q2_USD":-358877000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":117694000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":65635000.0,"CommonStockSharesAuthorized_0_Q2_shares":9500000000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":54590000.0,"InterestReceivableCurrent_0_Q2_USD":3636000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"DeferredIncomeTaxAssetsNet_0_Q2_USD":39801000.0,"OperatingIncomeLoss_2_Q2_USD":-732633000.0,"ShareBasedCompensation_2_Q2_USD":83723000.0,"FiniteLivedIntangibleAssetsGross_0_Q2_USD":8316000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":48980000.0,"AssetsNoncurrent_0_Q2_USD":510886000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":1805274000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":54138000.0,"StockholdersEquity_0_Q2_USD":2536298000.0,"AllowanceForDoubtfulAccountsReceivableWriteOffs_2_Q2_USD":0.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":46514000.0,"ProfitLoss_1_Q2_USD":-336318000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":3903290000.0,"ProfitLoss_2_Q2_USD":-701257000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.69,"RestrictedCashAndCashEquivalentsAtCarryingValue_0_Q2_USD":283000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q2_USD":375000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":12888000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":264735000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":45468000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":83723000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.33,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2_Q2_USD":-702646000.0,"Ticker":"BGNE","CIK":"1651308","name":"BEIGENE, LTD.","OfficialName":"BeiGene Ltd. American Depositary Shares","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"18163188203.0","Country":"Cayman Islands","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200806"}]